Pharmaceutical companies can contribute by offering patient assistance programs and pricing their drugs more affordably. They can also invest in the development of generic and [biosimilar drugs](#), which can significantly reduce costs. Collaboration with governments and NGOs can further enhance access to affordable cancer treatments.
